Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SILOAM: Adjunctive Cilostazol in Acute Myocardial Infarction
NCT01261832Phase 4Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- Jul 2011
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in acute myocardial infarction (AMI), sponsored by Korea University Guro Hospital. Status: unknown.
02
Drugs
cilostazol
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01261832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01261832.